Press Releases

Press Releases

03.24.20
OpGen Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Business Update for OpGen and Curetis Group
03.24.20
OpGen Provides Further Update on Shareholder Proxy Voting in Relation to the Business Combination with Curetis
03.23.20
OpGen Data Predicting Phenotypic Antimicrobial Susceptibility Published in Diagnostic Microbiology & Infectious Disease Journal
03.19.20
OpGen Provides Update on Shareholder Proxy Voting in Relation to the Business Combination with Curetis
03.16.20
OpGen Provides Update on Curetis Now Offering BGI’s CE-IVD Rapid Test Kit for Coronavirus in Europe
03.12.20
OpGen to Provide Business Update and Financial Results for the Fourth Quarter and Full Year 2019
03.10.20
Curetis N.V. Shareholders Approve Planned Business Combination with OpGen
02.20.20
OpGen Provides Update on Curetis Preliminary, Unaudited 2019 Condensed Combined Key Financials and Business Update
02.12.20
OpGen Announces Preliminary Unaudited Revenue for Fiscal 2019 and Provides Business Update
01.30.20
OpGen Provides Update on Curetis Group Company Ares Genetics’ Collaboration with BGI Group to Offer Next-Generation Sequencing and PCR-based Coronavirus (2019-nCoV) Testing in Europe